1-7 of 7
myelofibrosis, idiopathic, chronic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis

Clinical Trials & Observations
Sebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, Roberta Zini, Elisa Bianchi, Elena Genovese, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Selene Mallia, Lara Tavernari, Stefano Sartini, Margherita Mirabile, Carmela Mannarelli, Francesca Gesullo, Annalisa Pacilli, Daniela Pietra, Elisa Rumi, Silvia Salmoiraghi, Barbara Mora, Laura Villani, Andrea Grilli, Vittorio Rosti, Giovanni Barosi, Francesco Passamonti, Alessandro Rambaldi, Luca Malcovati, Mario Cazzola, Silvio Bicciato, Enrico Tagliafico, Alessandro M. Vannucchi, Rossella Manfredini
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1452–1462.
https://doi.org/10.1182/bloodadvances.2020003614
Published: 2021
Includes: Supplemental data
Journal Articles

A patient with a germline GATA2 mutation and primary myelofibrosis

Clinical Trials & Observations
Cyrill V. Rütsche, Eugenia Haralambieva, Veronika Lysenko, Stefan Balabanov, Alexandre P. A. Theocharides
Journal: Blood Advances
Blood Adv (2021) 5 (3): 791–795.
https://doi.org/10.1182/bloodadvances.2020003401
Published: 2021
Includes: Supplemental data
Journal Articles

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Clinical Trials & Observations
Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry Spivak, Linda Resar, Styliani Karanika, Donna M. Williams, Ophelia Rogers, Christopher D. Gocke, Alison R. Moliterno
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2567–2576.
https://doi.org/10.1182/bloodadvances.2019001407
Published: 2020
Includes: Supplemental data
Journal Articles

Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms

Junshik Hong, Ju Hyun Lee, Ja Min Byun, Ji Yun Lee, Youngil Koh, Dong-Yeop Shin, Jeong-Ok Lee, Sang Mee Hwang, Hyoung Soo Choi, Inho Kim, Sung-Soo Yoon, Soo-Mee Bang
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3700–3708.
https://doi.org/10.1182/bloodadvances.2019000655
Published: 2019
Includes: Supplemental data
Journal Articles

Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels

Clinical Trials & Observations
Ayalew Tefferi, Maura Nicolosi, Domenico Penna, Mythri Mudireddy, Natasha Szuber, Terra L. Lasho, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Animesh D. Pardanani
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1980–1984.
https://doi.org/10.1182/bloodadvances.2018018051
Published: 2018
Journal Articles

Targeted next-generation sequencing in blast phase myeloproliferative neoplasms

Clinical Trials & Observations
Terra L. Lasho, Mythri Mudireddy, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Natasha Szuber, Kebede H. Begna, Mrinal M. Patnaik, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2018) 2 (4): 370–380.
https://doi.org/10.1182/bloodadvances.2018015875
Published: 2018
Includes: Supplemental data
Journal Articles

Targeted deep sequencing in primary myelofibrosis

Clinical Trials & Observations
Ayalew Tefferi, Terra L. Lasho, Christy M. Finke, Yoseph Elala, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Animesh Pardanani
Journal: Blood Advances
Blood Adv (2016) 1 (2): 105–111.
https://doi.org/10.1182/bloodadvances.2016000208
Published: 2016
Includes: Supplemental data